TAKE CARE OF YOU AND YOUR PRACTICE DURING THIS PANDEMIC. WE ARE HERE TO HELP!

copd

June 16, 2015

Level of e-cigarette power contributes to potentially hazardous effects

The higher the power of an e-cigarette, the higher the concentrations of potentially hazardous substances the device produces, including acetaldehyde, acrolein, and formaldehyde. Those are among the findings presented at an international conference of the American Thoracic Society by lead study author Dr. Daniel Sullivan, an internal medicine resident at the University of Texas Southwestern…

May 19, 2015

Nudging Smokers

In the Issue of the New England Journal of Medicine an investigation of the role of financial incentives and nudges in promoting smoking cessation, with particular emphasis on the importance of loss aversion and pre-commitment is explored. In the past 40 years, we have seen a revolution in thinking about thinking.  The central idea is…

May 05, 2015

Market Forecast 2014-2024: Asthma and COPD Therapies

MD Spiro prides itself on not only offering incredible spirometry products for your practice, but also prides itself on providing articles and industry updates for our customers.  Below is a new study showing you trends, R&D progress, and predicted revenues in Asthma and COPD Therapies. So where’s the asthma and COPD therapies market heading? Visiongain’s…

April 20, 2015

Nationwide Climate Change Initiative Targets COPD and Asthma

Today, is Earth Day.  A statement released by the White House outlines an initiative to combat the health-related effects of climate change, with an emphasis on chronic obstructive pulmonary disease (COPD) and asthma.    “The Centers for Disease Control and Prevention (CDC) is releasing an Adaptation in Action Report highlighting successful actions state and local…

April 07, 2015

Testing for Inhaled Insulin

Diabetics now have a new option thanks to the breakthrough new medication AFREZZA®, an inhaled insulin now available by prescription.  The labeling for AFREZZA®, mandates spirometry testing (specifically FEV1) to rule out chronic lung disease prior to initiating therapy, six months after initiation and every year thereafter1.  MD Spiro offers a number of spirometer options…

March 24, 2015

Time is Right for E-Cig Regulation

Reducing the risks of e-cigarettes to smokers, encouraging the smoking-cessation potential, and restricting access by nonsmokers offer a regulatory trifecta that can be implemented immediately, according to a former FDA official. The “roadmap” to effective regulation hinges on implementation of the pending FDA deeming rule, which is expected to go into effect later this year….

January 25, 2015

Take Action to Fight Against Lung Disease

Join the American Lung Association in its effort to eliminate tobacco-caused death and disease! By taking action to prevent and reduce tobacco use in your state, you are standing with the American Lung Association to advance the fight against lung disease. As part of the American Lung Association Action Network, you can also take action…

January 11, 2015

Asthma, COPD Linked With More Inflammatory Bowel Disease

In this New Year, it is important for us to be educated about new studies that have come out in reference to airway management, asthma, COPD, and more.  A higher incidence of inflammatory bowel disease (IBD) has been found in persons with airway diseases, such as asthma and COPD, in a study published online ahead…